Matches in Nanopublications for { ?s ?p "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP364317.RAUGqtmk584zEicZAkqoYpvsxHvK3iAeI5W99_mFWk9RI130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364317.RAUGqtmk584zEicZAkqoYpvsxHvK3iAeI5W99_mFWk9RI130_provenance.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.
- NP502406.RAA-Nf8I7kXGUCAgTG9C4DdXWuk3rv2cwjAI6aqVkeIMA130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502406.RAA-Nf8I7kXGUCAgTG9C4DdXWuk3rv2cwjAI6aqVkeIMA130_provenance.
- NP502407.RAjiHl2656-1OUYF3HhkAJn0lFCQeF3eanS5EcI4PaA40130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502407.RAjiHl2656-1OUYF3HhkAJn0lFCQeF3eanS5EcI4PaA40130_provenance.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.